Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Bunnell

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2014
Measuring opportunities to improve timeliness of breast cancer care at Dana-Farber/Brigham and Women's Cancer CenterCraig A Bunnell, Katya Losk, Sarah Kadish, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2016
Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer CenterKatya Losk, Ines Vaz-Luis, Kristen Camuso, et al.
Journal of the American College of Radiology : JACR|December 24, 2018
Clinical Impact of Second Opinion Radiology Consultation for Patients With Breast CancerDebra S Whorms, Catherine S Giess, Mehra Golshan, et al.
Journal of Oncology Practice|September 8, 2016
Teamwork and Electronic Health Record Implementation: A Case Study of Preserving Effective Communication and Mutual Trust in a Changing EnvironmentAnne H Gross, Ryan K Leib, Anne Tonachel, et al.
Journal of Oncology Practice|September 1, 2017
Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy InitiationKatya Losk, Rachel A Freedman, Nancy U Lin, et al.
The Oncologist|August 5, 2018
Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing CriteriaKelsey H Natsuhara, Katya Losk, Tari A King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapyJeffrey A Meyerhardt, Denise Heseltine, Hannia Campos, et al.
International Journal of Clinical Oncology|April 21, 2010
Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancerSusana M Campos, Suzanne T Berlin, Leroy M Parker, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 21, 2017
Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility StudyShoshana M Rosenberg, Jennifer A Ligibel, Jeffrey A Meyerhardt, et al.
Cancer Chemotherapy and Pharmacology|February 15, 2021
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancerFilipa Lynce, James T Williams, Meredith M Regan, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2014
Measuring opportunities to improve timeliness of breast cancer care at Dana-Farber/Brigham and Women's Cancer CenterCraig A Bunnell, Katya Losk, Sarah Kadish, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2016
Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer CenterKatya Losk, Ines Vaz-Luis, Kristen Camuso, et al.
Journal of the American College of Radiology : JACR|December 24, 2018
Clinical Impact of Second Opinion Radiology Consultation for Patients With Breast CancerDebra S Whorms, Catherine S Giess, Mehra Golshan, et al.
Journal of Oncology Practice|September 8, 2016
Teamwork and Electronic Health Record Implementation: A Case Study of Preserving Effective Communication and Mutual Trust in a Changing EnvironmentAnne H Gross, Ryan K Leib, Anne Tonachel, et al.
Journal of Oncology Practice|September 1, 2017
Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy InitiationKatya Losk, Rachel A Freedman, Nancy U Lin, et al.
The Oncologist|August 5, 2018
Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing CriteriaKelsey H Natsuhara, Katya Losk, Tari A King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapyJeffrey A Meyerhardt, Denise Heseltine, Hannia Campos, et al.
International Journal of Clinical Oncology|April 21, 2010
Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancerSusana M Campos, Suzanne T Berlin, Leroy M Parker, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 21, 2017
Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility StudyShoshana M Rosenberg, Jennifer A Ligibel, Jeffrey A Meyerhardt, et al.
Cancer Chemotherapy and Pharmacology|February 15, 2021
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancerFilipa Lynce, James T Williams, Meredith M Regan, et al.
Pageof 3